IT’S NOT JUST CLINICAL LABORATORIES seeking ways to repurpose the analyzers and automation they used to perform SARS-CoV-2 testing. As the pandemic continues to ease, some in vitro diagnostics (IVD) companies want to help their lab customers by expanding the types of diagnostic tests than can be run on these instrument systems. This is true […]
- IVD Update
Thermo Fisher Expands Menu to Offset COVID-19 Decreases
- By Scott Wallask
- > From the Volume XXIX, No. 14 - October 10, 2022 Issue
